KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Thermo Fisher Scientific (TMO) Receivables - Other (2018 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Receivables - Other for 7 consecutive years, with $1.5 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Receivables - Other rose 5.19% year-over-year to $1.5 billion, compared with a TTM value of $1.5 billion through Sep 2024, up 5.19%, and an annual FY2023 reading of $1.4 billion, up 9.98% over the prior year.
  • Receivables - Other was $1.5 billion for Q3 2024 at Thermo Fisher Scientific, up from $1.5 billion in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.5 billion in Q3 2024 and bottomed at $658.0 million in Q1 2020.
  • Average Receivables - Other over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2022.
  • The sharpest move saw Receivables - Other skyrocketed 54.46% in 2022, then rose 1.36% in 2024.
  • Year by year, Receivables - Other stood at $731.0 million in 2020, then skyrocketed by 32.42% to $968.0 million in 2021, then surged by 35.54% to $1.3 billion in 2022, then grew by 9.98% to $1.4 billion in 2023, then rose by 6.79% to $1.5 billion in 2024.
  • Business Quant data shows Receivables - Other for TMO at $1.5 billion in Q3 2024, $1.5 billion in Q2 2024, and $1.4 billion in Q1 2024.